Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription

Articles published in J Surg Oncol

Retrieve available abstracts of 85 articles:
HTML format

Single Articles

    January 2022
  1. FOSTER JM, Alexander HR, Zhang C
    Regional therapy trials in peritoneal metastases: The path to standardization-Colorectal cancer.
    J Surg Oncol. 2022;125:57-63.

  2. WHELAN S, Burneikis D, Kalady MF
    Rectal cancer: Maximizing local control and minimizing toxicity.
    J Surg Oncol. 2022;125:46-54.
    PubMed     Abstract available

    December 2021
  3. CHODOFF A, Smith KC, Shukla A, Blackford AL, et al
    Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations.
    J Surg Oncol. 2021 Dec 11. doi: 10.1002/jso.26767.
    PubMed     Abstract available

  4. SERRANO PE, Parpia S, Karanicolas P, Gallinger S, et al
    Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial.
    J Surg Oncol. 2021 Dec 8. doi: 10.1002/jso.26764.
    PubMed     Abstract available

  5. KIM JC, Ha YJ, Park IJ, Kim CW, et al
    Tumor immune microenvironment of primary colorectal adenocarcinomas metastasizing to the liver or lungs.
    J Surg Oncol. 2021;124:1136-1145.
    PubMed     Abstract available

  6. YANG W, Liu Q, Lin G, Zhang B, et al
    The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    J Surg Oncol. 2021;124:1128-1135.
    PubMed     Abstract available

  7. YOON DH, Ibrahim A, Tatishchev S, Duldulao MPN, et al
    Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
    J Surg Oncol. 2021;124:1091-1097.
    PubMed     Abstract available

  8. WANG Y, Zhang Y, Lin H, Xu M, et al
    Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
    J Surg Oncol. 2021;124:1098-1105.
    PubMed     Abstract available

  9. LI Z, Wang Y, Ying X, Zhang L, et al
    Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
    J Surg Oncol. 2021;124:1356-1364.
    PubMed     Abstract available

  10. MENG W, Yang B, Huang B, Chen C, et al
    Impact of preoperative transcatheter rectal arterial chemoembolization with concurrent chemoradiotherapy on surgery and prognosis of patients with locally advanced rectal cancer.
    J Surg Oncol. 2021;124:1451-1458.
    PubMed     Abstract available

  11. DAMASCENO AM, Kesley R, Paolino BS, Dos Santos do Amaral MR, et al
    Perioperative score for octogenarian patients eligible for rectal cancer surgery.
    J Surg Oncol. 2021;124:1409-1416.
    PubMed     Abstract available

  12. KAZI M, Jain D, Padhy AS, Menon M, et al
    Optimal neoadjuvant strategy for signet ring cell carcinoma of the rectum-Is TNT the solution?
    J Surg Oncol. 2021;124:1417-1430.
    PubMed     Abstract available

    November 2021
  13. BRAJCICH BC, Benson AB, Gantt G, Eng OS, et al
    Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
    J Surg Oncol. 2021 Nov 25. doi: 10.1002/jso.26758.
    PubMed     Abstract available

  14. HU Q, Sun YS, Yang XY
    Comment on "Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure".
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26580.

    October 2021
  15. NUMATA M, Shiozawa M, Godai T, Kazama K, et al
    Prediction of lateral lymph node metastasis using OSNA method for mesorectal lymph nodes in low rectal cancer: A prospective study by the Kanagawa Yokohama Colorectal Cancer Study Group (KYCC1801).
    J Surg Oncol. 2021 Oct 27. doi: 10.1002/jso.26730.
    PubMed     Abstract available

  16. TURGEON MK, Gamboa AC, Keilson JM, Maniko J, et al
    Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium.
    J Surg Oncol. 2021;124:818-828.
    PubMed     Abstract available

  17. INOUE H, Kawaguchi T, Ikoma H, Morimura R, et al
    Oligometastasis scoring system for predicting survival of patients with colorectal liver metastasis after hepatectomy.
    J Surg Oncol. 2021;124:791-800.
    PubMed     Abstract available

  18. LAU LW, Kethman WC, Bingmer KE, Ofshteyn A, et al
    Evaluating disparities in delivery of neoadjuvant guideline-based chemoradiation for rectal cancer: A multicenter, propensity score-weighted cohort study.
    J Surg Oncol. 2021;124:810-817.
    PubMed     Abstract available

    September 2021
  19. REUDINK M, Molenaar CJL, Bonhof CS, Janssen L, et al
    Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
    J Surg Oncol. 2021 Sep 27. doi: 10.1002/jso.26685.
    PubMed     Abstract available

  20. WANG HW, Wang LJ, Jin KM, Bao Q, et al
    The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    J Surg Oncol. 2021;124:619-626.
    PubMed     Abstract available

  21. FENG Q, Ng SSM, Zhang Z, Lin S, et al
    Comparison between robotic natural orifice specimen extraction surgery and traditional laparoscopic low anterior resection for middle and low rectal cancer: A propensity score matching analysis.
    J Surg Oncol. 2021;124:607-618.
    PubMed     Abstract available

  22. KONISHI T, Yoshidome H, Shida T, Furukawa K, et al
    Phosphorylated mTOR expression as a predictor of survival after liver resection for colorectal liver metastases.
    J Surg Oncol. 2021;124:598-606.
    PubMed     Abstract available

  23. DETERING R, Meyer VM, Borstlap WAA, Beets-Tan RGH, et al
    Prognostic importance of lymph node count and ratio in rectal cancer after neoadjuvant chemoradiotherapy: Results from a cross-sectional study.
    J Surg Oncol. 2021;124:367-377.
    PubMed     Abstract available

  24. ZHOU S, Jiang Y, Pei W, Zhou H, et al
    Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications.
    J Surg Oncol. 2021;124:354-360.
    PubMed     Abstract available

    August 2021
  25. ZHANG C, Wang X, Han J, Zhang R, et al
    Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients.
    J Surg Oncol. 2021 Aug 18. doi: 10.1002/jso.26651.
    PubMed     Abstract available

  26. DE ROOS MAJ, Hugen N, Hazebroek EJ, Spillenaar Bilgen EJ, et al
    Delayed surgical resection of primary left-sided obstructing colon cancer is associated with improved short- and long-term outcomes.
    J Surg Oncol. 2021 Aug 4. doi: 10.1002/jso.26632.
    PubMed     Abstract available

    July 2021
  27. ZHANG LM, Schuitevoerder D, White MG, Feldt S, et al
    Combined mechanical and oral antibiotic bowel preparation is associated with prolonged recurrence-free survival following surgery for colorectal cancer.
    J Surg Oncol. 2021 Jul 26. doi: 10.1002/jso.26619.
    PubMed     Abstract available

  28. LWIN TM, Turner MA, Amirfakhri S, Nishino H, et al
    Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    J Surg Oncol. 2021 Jul 26. doi: 10.1002/jso.26623.
    PubMed     Abstract available

  29. TODATE Y, Honda M, Takada T, Saginoya T, et al
    The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
    J Surg Oncol. 2021 Jul 14. doi: 10.1002/jso.26602.
    PubMed     Abstract available

  30. DIAZ A, Dalmacy D, Hyer JM, Tsilimigras D, et al
    Intersection of social vulnerability and residential diversity: Postoperative outcomes following resection of lung and colon cancer.
    J Surg Oncol. 2021 Jul 1. doi: 10.1002/jso.26588.
    PubMed     Abstract available

    June 2021
  31. PATEL S, Sukumar V, Kazi M, Saklani A, et al
    Safety and feasibility of sphincter preservation surgery in low lying rectal cancers.
    J Surg Oncol. 2021;123:1651-1652.

  32. DREFS M, Schoenberg MB, Schiergens TS, Albertsmeier M, et al
    Chances, challenges and outcomes of patients with complex bilobar colorectal liver metastases approached by a combined multimodal therapy with liver resection and local ablative therapy.
    J Surg Oncol. 2021;123:1578-1591.
    PubMed     Abstract available

    May 2021
  33. SUGARBAKER PH, Deng T, Chang D
    Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancer.
    J Surg Oncol. 2021 May 7. doi: 10.1002/jso.26520.
    PubMed     Abstract available

  34. JIANG TY, Zang L, Dong F, Feng B, et al
    Effect of different reinforcement methods on anastomotic leakage prevention after laparoscopic double anastomosis.
    J Surg Oncol. 2021;123 Suppl 1:S81-S87.
    PubMed     Abstract available

  35. LI R, Shen K, Wang Z, Xie Z, et al
    Short-term outcomes of medium-low rectal cancer treated by taTME and experience of 22 cases.
    J Surg Oncol. 2021;123 Suppl 1:S52-S58.
    PubMed     Abstract available

  36. FENG W, Zong Y, Zhao J, Li W, et al
    High versus low ligation of the inferior mesenteric artery during laparoscopic rectal cancer surgery: A prospective study of surgical and oncological outcomes.
    J Surg Oncol. 2021;123 Suppl 1:S76-S80.
    PubMed     Abstract available

  37. JIANG TY, Ma JJ, Zheng MH
    Controversies and consensus in transanal total mesorectal excision (taTME): Is it a valid choice for rectal cancer?
    J Surg Oncol. 2021;123 Suppl 1:S59-S64.
    PubMed     Abstract available

  38. ZHAO X, Ma J, Fu Z, Hong H, et al
    Prognostic value of apical lymph node metastasis at the inferior mesenteric artery in sigmoid and rectal cancer patients who undergo laparoscopic surgery.
    J Surg Oncol. 2021;123 Suppl 1:S88-S94.
    PubMed     Abstract available

  39. XIAO Y, Lin C, Lu JY, Xu L, et al
    Short-term outcomes of pure transvaginal laparoscopic right colectomy: A novel surgery approach based on an Idea, Development, Exploration, Assessment, Long-term framework stage IIa study.
    J Surg Oncol. 2021;123 Suppl 1:S36-S42.
    PubMed     Abstract available

  40. AN YB, Yao HW, Yang XH, Zhang X, et al
    Verification of data in a nationwide transanal total mesorectal excision registry in China.
    J Surg Oncol. 2021;123 Suppl 1:S43-S51.
    PubMed     Abstract available

  41. HONG HJ, Zhao X, Yu CR, Sun J, et al
    Comparative study of oncologic efficacy of cephalomedial to lateral dissection versus medial to lateral dissection in laparoscopic total mesorectal excision for rectal cancer: An RCT study.
    J Surg Oncol. 2021;123 Suppl 1:S65-S75.
    PubMed     Abstract available

  42. BOHLOK A, Duran Derijckere I, Azema H, Lucidi V, et al
    Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases.
    J Surg Oncol. 2021;123:1773-1783.
    PubMed     Abstract available

  43. KAZI M, Bhamre R, DeSouza A, Ostwal V, et al
    Long-term oncological outcomes of the sphincter preserving total mesorectal excision with varying distal resection margins.
    J Surg Oncol. 2021;123:1784-1791.
    PubMed     Abstract available

    April 2021
  44. OZAWA T, Matsuda K, Ishihara S, Fukushima Y, et al
    The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    J Surg Oncol. 2021 Apr 13. doi: 10.1002/jso.26497.
    PubMed     Abstract available

  45. BEHRENBRUCH C, Prabhakaran S, Udayasiri D D, Michael M, et al
    Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    J Surg Oncol. 2021;123:1263-1273.
    PubMed     Abstract available

    March 2021
  46. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed     Abstract available

  47. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Stathmin expression in metastatic colorectal cancer.
    J Surg Oncol. 2021 Mar 25. doi: 10.1002/jso.26464.
    PubMed     Abstract available

  48. FELDMAN HA, Zhou N, Antonoff MB, Hofstetter WL, et al
    Simultaneous versus staged resections for bilateral pulmonary metastases.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26392.
    PubMed     Abstract available

  49. LUMISH MA, Cercek A
    Immunotherapy for the treatment of colorectal cancer.
    J Surg Oncol. 2021;123:760-774.
    PubMed     Abstract available

  50. SUN Y, Zhang D, Feng Y, Wang Y, et al
    Infrapyloric lymph node dissection in right hemicolectomy for colon cancer: Should prophylactic resection be recommended?
    J Surg Oncol. 2021 Mar 1. doi: 10.1002/jso.26388.
    PubMed     Abstract available

  51. GRASS F, Merchea A, Mathis KL, Mishra N, et al
    Cost drivers of locally advanced rectal cancer treatment-An analysis of a leading healthcare insurer.
    J Surg Oncol. 2021;123:1023-1029.
    PubMed     Abstract available

  52. DENADAI MVA, Melani AGF, Neto MC, Romagnolo LGC, et al
    Robotic rectal surgery: Outcomes of the first 102 totally robotic cases handled using the single-docking technique in a reference institution.
    J Surg Oncol. 2021;123:997-1004.
    PubMed     Abstract available

    February 2021
  53. WILLIAMS AD, Sun T, Kakade S, Wong SL, et al
    Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure.
    J Surg Oncol. 2021 Feb 12. doi: 10.1002/jso.26298.
    PubMed     Abstract available

  54. LE VH, Thornblade L, Ituarte PHG, Lai LL, et al
    Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
    J Surg Oncol. 2021;123:622-629.
    PubMed     Abstract available

  55. MURPHY C, Stephens I, OFlanagan G, OByrne L, et al
    A comparison of oncological outcomes after abdominoperineal excision before and after the implementation of a selective perineal flap closure program.
    J Surg Oncol. 2021;123:614-621.
    PubMed     Abstract available

    January 2021
  56. ISHIMARU K, Kawai K, Nozawa H, Sasaki K, et al
    Hazard function analysis of metastatic recurrence after colorectal cancer surgery-A nationwide retrospective study.
    J Surg Oncol. 2021 Jan 14. doi: 10.1002/jso.26378.
    PubMed     Abstract available

  57. KAMPHUES C, Andreatos N, Kruppa J, Buettner S, et al
    The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
    J Surg Oncol. 2021 Jan 5. doi: 10.1002/jso.26361.
    PubMed     Abstract available

  58. DE NARDI P, Mistrangelo M, Burtulo G, Passoni P, et al
    Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy.
    J Surg Oncol. 2021;123:315-321.
    PubMed     Abstract available

  59. LEIPHRAKPAM PD, Chowdhury S, Wang J, Black JD, et al
    The role and therapeutic implications of PI3K signaling pathway in cancer.
    J Surg Oncol. 2021;123:39-41.

  60. EL ASMAR A, Veys I, Larsimont D, Donckier V, et al
    Inferior epigastric artery lymph nodes: A pathway for systemic dissemination from peritoneal carcinomatosis?
    J Surg Oncol. 2021;123:311-314.
    PubMed     Abstract available

  61. ROUANET P, Rivoire M, Gourgou S, Lelong B, et al
    Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?
    J Surg Oncol. 2021;123:299-310.
    PubMed     Abstract available

  62. MUADDI H, D'Angelica M, Wiseman JT, Dillhoff M, et al
    Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    J Surg Oncol. 2021;123:252-260.
    PubMed     Abstract available

  63. CHUAN L, Linfeng G, Hongchang L, Xiaosong W, et al
    Short-term outcomes of pelvic floor peritoneum closure in endoscopic low anterior resection of rectal cancer: A propensity score matching analysis.
    J Surg Oncol. 2021;123:271-277.
    PubMed     Abstract available

  64. SELL NM, Qwaider YZ, Goldstone RN, Cauley CE, et al
    Ten-year survival after pathologic complete response in rectal adenocarcinoma.
    J Surg Oncol. 2021;123:293-298.
    PubMed     Abstract available

  65. KOIZUMI M, Yamada T, Shinji S, Matsuda A, et al
    Even a partial pathological response is associated with lower relapse rates in patients with operable rectal cancer undergoing neoadjuvant chemotherapy.
    J Surg Oncol. 2021;123:286-292.
    PubMed     Abstract available

  66. ZHOU P, Goffredo P, Ginader T, Thompson D, et al
    Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.
    J Surg Oncol. 2021;123:278-285.
    PubMed     Abstract available

  67. LEE RM, Gamboa AC, Turgeon MK, Zaidi MY, et al
    A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
    J Surg Oncol. 2021;123:187-195.
    PubMed     Abstract available

  68. MCKENNA NP, Bews KA, Colibaseanu DT, Mathis KL, et al
    The intersection of tumor location and combined bowel preparation: Utilization differs but anastomotic leak risk reduction does not.
    J Surg Oncol. 2021;123:261-270.
    PubMed     Abstract available

    December 2020
  69. KAMPHUES C, Kadowaki S, Amini N, van den Berg I, et al
    The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
    J Surg Oncol. 2020 Dec 23. doi: 10.1002/jso.26352.
    PubMed     Abstract available

  70. PARK YY, Lee J, Han YD, Cho MS, et al
    Survival outcomes after isolated local recurrence of rectal cancer and risk analysis affecting its resectability.
    J Surg Oncol. 2020;122:1470-1480.
    PubMed     Abstract available

  71. BENOIT O, Svrcek M, Creavin B, Bouquot M, et al
    Prognostic value of tumor deposits in rectal cancer: A monocentric series of 505 patients.
    J Surg Oncol. 2020;122:1481-1489.
    PubMed     Abstract available

  72. SROUJI RM, Narayan RR, Boerner T, Buisman FE, et al
    Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.
    J Surg Oncol. 2020;122:1536-1542.
    PubMed     Abstract available

  73. SAKAMOTO T, Hida K, Hoshino N, Yamaguchi T, et al
    Changes in the sexual function of male patients with rectal cancer over a 2-year period from diagnosis to 24-month follow-up: A prospective, multicenter, cohort study.
    J Surg Oncol. 2020;122:1647-1654.
    PubMed     Abstract available

  74. VASAN K, Anand S, Satgunaseelan L, Asher R, et al
    Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma.
    J Surg Oncol. 2020;122:1755-1760.
    PubMed     Abstract available

    November 2020
  75. PATA G, Bianchetti L, Rota M, Marengoni A, et al
    Multidimensional Prognostic Index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: The FRAGIS study.
    J Surg Oncol. 2020 Nov 25. doi: 10.1002/jso.26314.
    PubMed     Abstract available

  76. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Correlation of PRL3 expression with colorectal cancer progression.
    J Surg Oncol. 2020 Nov 12. doi: 10.1002/jso.26253.
    PubMed     Abstract available

  77. AZIN A, Hirpara DH, Draginov A, Khorasani M, et al
    Adequacy of lymph node harvest following colectomy for obstructed and nonobstructed colon cancer.
    J Surg Oncol. 2020 Nov 3. doi: 10.1002/jso.26274.
    PubMed     Abstract available

  78. AUGUSTIN T, Moslim MA, Cengiz TB, El-Hayek K, et al
    Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
    J Surg Oncol. 2020;122:1132-1144.
    PubMed     Abstract available

  79. GIESEN LJX, Borstlap WAA, Bemelman WA, Tanis PJ, et al
    Effect of understaging on local recurrence of rectal cancer.
    J Surg Oncol. 2020;122:1179-1186.
    PubMed     Abstract available

    October 2020
  80. ALESE OB, Zakka K, Huo X, Jiang R, et al
    Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
    J Surg Oncol. 2020 Oct 30. doi: 10.1002/jso.26278.
    PubMed     Abstract available

  81. SUAREZ J, Mata E, Guerra A, Jimenez G, et al
    Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer.
    J Surg Oncol. 2020 Oct 19. doi: 10.1002/jso.26263.
    PubMed     Abstract available

    Considerations for transanal surgery during COVID-19 pandemic.
    J Surg Oncol. 2020;122:995.

  83. DE CRIGNIS L, Slim K, Cotte E, Meillat H, et al
    Impact of surgical indication on patient outcomes and compliance with enhanced recovery program for colorectal surgery: A Francophone multicenter retrospective analysis.
    J Surg Oncol. 2020;122:928-933.
    PubMed     Abstract available

  84. NICHOLS DS, Satteson E, Harbor P, DeFranzo A, et al
    Factors associated with the use of vertical rectus abdominus myocutaneous flap reconstruction following abdominoperineal resection for anorectal cancer.
    J Surg Oncol. 2020;122:923-927.
    PubMed     Abstract available

    September 2020
  85. RAOOF M, Fong Y
    Liver resection for colorectal cancer liver metastases: An often-neglected opportunity for cure.
    J Surg Oncol. 2020 Sep 24. doi: 10.1002/jso.26192.

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.